Breakthrough at Stanford: Engineered Natural Killer Cells Open the Door to Effective Solid Tumor Immunotherapy
Executive Overview While cell-based immunotherapies have revolutionized the therapeutic landscape for liquid tumors—such as leukemias and lymphomas—solid tumors have historically...